Ticker Symbol: OCGN
Ocugen Inc
$8.13 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001372299
Company Profile
Ocugen, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. Its breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug - "one to many" and its novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema, and diabetic retinopathy. The Company is co-developing Bharat Biotech's COVAXIN™ vaccine candidate for COVID-19 in the U.S. market.
Sector: Manufacturing
Industry: Sanitary Paper Product Manufacturing
Standard Industrial Classification Code (SIC code): 3842
Address: 5 Great Valley Pkwy Ste 160
Website: ocugen.com
CEO: Shankar Musunuri
Tags:
- Health Technology
- Biotechnology
- Pharmaceuticals: Major
- Manufacturing
- Sanitary Paper Product Manufacturing
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $0.40
Change:
$0.00
(
1.90%)
Days Range: $0.39 - $0.40
Beta: 2.28
52wk. High: $1.87
52wk. Low: $0.39
Ytd. Change -67.30%
50 Day Moving Average: $0.41
200 Day Moving Average: $0.54
Shares Outstanding: 256488914
Valuation
Market Cap: 10.5B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A